Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult Participants
Sponsor: AbbVie
Summary
The objective of this study is to assess the pharmacokinetic (PK), immunogenicity, safety, and tolerability of ABBV-1451 after single ascending doses in healthy adult volunteers.
Official title: A First in Human, Single Ascending Dose Study of ABBV-1451 to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability in Healthy Subjects and in Japanese and Han Chinese Healthy Subjects
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
90
Start Date
2026-04-28
Completion Date
2027-04
Last Updated
2026-05-06
Healthy Volunteers
Yes
Conditions
Interventions
ABBV-1451
Injection
ABBV-1451
Infusion
Placebo
Injection
Placebo
Infusion
Locations (1)
Acpru /Id# 282128
Grayslake, Illinois, United States